Impact of Anti‐Endometrial Antibodies on IVF Implantation and Pregnancy Outcomes: A Retrospective Study
Our study observed that the presence of EMAb was associated with less favorable IVF outcomes, primarily reflected in lower implantation and clinical pregnancy rates. However, once the implantation was successful, the risk of miscarriage did not increase. These findings suggest a potential role for EMAb screening in guiding personalized treatment strategies, such as increasing the number of embryos transferred or using immunosuppressive agents, to improve IVF outcomes. Future research should involve more extensive and diverse populations to explore the mechanisms of action of EMAb and their impact on IVF treatment outcomes.
Authors
- Xiaojing Hou (ORCID: https://orcid.org/0000-0003-1044-3617)
- Huiqing An
- Yan Su (ORCID: https://orcid.org/0000-0001-9036-4227)
- Yuhe Wang (ORCID: https://orcid.org/0000-0002-9830-5149)
- Juan Zhang (ORCID: https://orcid.org/0000-0001-6241-7176)
- Yaping Guo (ORCID: https://orcid.org/0000-0002-7358-2377)
- Xiufeng Ling
- Rong Shen
- Shuangshuang Zhao
- Mianqiu Zhang
Institutions
- Nanjing Maternity and Child Health Care Hospital (CN)
Publication Details
- Journal
- American Journal of Reproductive Immunology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1111/aji.70202
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00